Please login to the form below
J&J gets EU green light for novel TB drug
Sirturo approved to treat multidrug resistant form of the disease
Novartis' dermatology plans advance with Xolair approval
Green light for use in chronic spontaneous urticaria
Lilly/Boehringer's empagliflozin faces US approval delay
FDA cites manufacturing issues with the new diabetes drug
Pfizer recalls depression drug in US
Wrong medicine found in bottle of Effexor XR
Five companies breach ABPI code
Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline named by PMCPA
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
Use data responsibly
It’s imperative that opening up clinical trial data doesn’t compromise patient safety
Patients and HCPs turn first to Wikipedia
The online encyclopedia is now the leading source of medical information
Featured jobs
- Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.
- Salary up to £65,000
- Account Associate
- On application
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
- Business Development Director
- Competitive Salary Offered
- Account Director – PR Healthcare
- Excellent salary and package
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Planning Director
- Circa £100,000 with Extensive Package
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Account Director - Medical Education
- Competitive + excellent benefits
- Account Director
- up to 60k
- Account Director- Healthcare
- Highly Competitive Salary
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
Subscribe to our email news alerts
PMHub
Just::Health Communications
Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...
Latest intelligence
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
- Biosimilars: friend or foe for healthcare systems?
- They present a significant opportunity in Europe, but achieving widespread acceptance and uptake of biosimilars is by no means a done deal...
Quick links
